RCC
Les récepteurs des chimiokines C-C (CCRs) sont un groupe de GPCR qui répondent aux chimiokines, des molécules de signalisation qui guident la migration des cellules immunitaires vers les sites d'inflammation ou d'infection. Les CCR jouent un rôle crucial dans les réponses immunitaires, l'inflammation et le développement de diverses maladies, y compris les troubles auto-immuns et le cancer. La modulation de l'activité des CCR est explorée comme une stratégie thérapeutique pour des affections telles que la polyarthrite rhumatoïde, la sclérose en plaques et l'infection par le VIH. Chez CymitQuimica, nous offrons une gamme de modulateurs de CCR de haute qualité pour soutenir vos recherches en immunologie, inflammation et développement thérapeutique.
135 produits trouvés pour "RCC"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
RP-23618
CAS :RP-23618 is a non-peptidic antagonist of RANTES.Formule :C30H35N5O3S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :577.76VCH-286
CAS :VCH-286 is a C-C chemokine receptor type 5 (CCR5) receptor antagonist.Formule :C34H50F2N4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :600.78(1S)-CCR2 antagonist 1
CAS :(1S)-CCR2 antagonist 1, a left-handed chiral form of CCR2 antagonist 1, exhibits high affinity and a long residence time as a CCR2 antagonist, with an inhibition constant (K i) of 2.4 nM [1].Formule :C28H32BrF3N2OCouleur et forme :SolidMasse moléculaire :549.47(Rac)-PF-4136309(1341224-83-6 Free base)
CAS :PF-4136309 (INCB8761, PF-04136309) is a highly effective and selective oral CCR2 antagonist with good bioavailability, with an IC50 value of 5.2 nM for humanFormule :C29H31F3N6O3Couleur et forme :SolidMasse moléculaire :568.59CCR2 antagonist 4
CAS :CCR2 antagonist 4 (Teijin compound 1) is a potent and specific antagonist of CCR2(IC50s of 180 nM), and potently inhibits MCP-1-induced chemotaxis(IC50 of 24 nMFormule :C21H21ClF3N3O2Degré de pureté :99.86%Couleur et forme :SolidMasse moléculaire :439.86Ref: TM-T13114
1mg52,00€5mg120,00€10mg188,00€25mg329,00€50mg490,00€100mg697,00€1mL*10mM (DMSO)133,00€PF-04634817
CAS :PF-0463481: safe, well-tolerated, dual CCR2/CCR5 antagonist for diabetic nephropathy; similar human/rodent CCR2 potency, less rodent CCR5 effect.Formule :C25H36F3N5O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :511.58PF-04634817 succinate
CAS :PF-0463481 succinate is a potent and orally active dual antagonist of CCR2/CCR5 with comparable human and rodent CCR2 potency with IC50 of 20.8 nM.Formule :C29H42F3N5O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :629.67CCR4 antagonist 4
CAS :CCR4 Antagonist 4 (Compound 22) is a potent and selective antagonist of the CC chemokine receptor-4 (CCR4), displaying an IC50 value of 0.02 μM. It also inhibits MDC-mediated chemotaxis and Ca2+ mobilization, with IC50 values of 0.007 μM and 0.003 μM, respectively. This compound is utilized in research on allergic inflammation [1].Formule :C24H27Cl2N7OCouleur et forme :SolidMasse moléculaire :500.42SB-649701
CAS :SB-649701 is a potent antagonist of the human CCR8 receptor, exhibiting a pIC50 value of 7.7, and is utilized in asthma research [1].Formule :C27H28N4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :456.54MLN-3897
CAS :MLN-3897 is an oral CCR1 antagonist, Ki 2.3 nM, blocks 125I-MIP-1α binding, and inhibits Akt signaling in MM cells.Formule :C30H31ClN2O4Degré de pureté :98.62%Couleur et forme :SolidMasse moléculaire :519.03CCR3 antagonist 1
CAS :CCR3 antagonist 1 is a potent CCR3 antagonist, used for the research of inflammatory and immunologic diseases.Formule :C19H21Cl2N3O4S2Degré de pureté :98.28%Couleur et forme :SolidMasse moléculaire :490.42Ref: TM-T10156
1mg92,00€5mg188,00€10mg305,00€25mg489,00€50mg655,00€100mg883,00€1mL*10mM (DMSO)224,00€K777
CAS :K777: Oral cysteine protease inhibitor, CYP3A4 blocker (IC50=60 nM), CCR4 antagonist, anti-Trypanosoma cruzi, antiviral, halts EBOV/SARS-CoV entry (IC50<1 nM).Formule :C32H38N4O4SDegré de pureté :98.43% - 99.14%Couleur et forme :SolidMasse moléculaire :574.73INCB3344
CAS :INCB3344 is an effective, specific and orally bioavailable CCR2 antagonist with IC50 values of 9.5 nM (mCCR2) and 5.1 nM (hCCR2) in binding antagonism and 7.8Formule :C29H34F3N3O6Degré de pureté :98% - 98.2%Couleur et forme :SolidMasse moléculaire :577.59Ref: TM-TQ0103
1mg66,00€5mg144,00€10mg230,00€25mg358,00€50mg512,00€100mg707,00€200mg973,00€1mL*10mM (DMSO)178,00€Aplaviroc hydrochloride
CAS :Aplaviroc, a potent CCR5 inhibitor, binds selectively, blocking HIV entry and specific monoclonal antibody attachment in vitro.Formule :C33H44ClN3O6Couleur et forme :SolidMasse moléculaire :614.17CCR1 antagonist 13
CAS :CCR1 antagonist13 is a selective small molecule antagonist of CCR1.Formule :C25H27ClFN3O4Couleur et forme :SolidMasse moléculaire :487.95CCR1 antagonist 11 hydrochloride
Oral CCR1 antagonist A1B1 targets h/m/rCCR1 (IC50: 0.03/0.58/0.32 μM), potential for treating inflammatory diseases.Couleur et forme :SolidPF-07054894
CAS :PF-07054894: potent CCR6 antagonist, targets GPCR, for inflammatory bowel disease research.Formule :C24H30N6O4Couleur et forme :SolidMasse moléculaire :466.53Aplaviroc
CAS :Aplaviroc (AK 602), a SDP derivative, is a CCR5 antagonist. With IC50s of 0.1-0.4 nM for HIV-1Ba-L, HIV-1JRFL and HIV-1MOKW.Formule :C33H43N3O6Degré de pureté :97.98% - 98.26%Couleur et forme :SolidMasse moléculaire :577.71CCR5 antagonist 1
CAS :CCR5 antagonist 1 is a CCR5 antagonist extracted from WO 2004054974 A2. It can inhibit HIV replication.Formule :C39H46ClF2N5O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :738.33BMS-741672
CAS :BMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain.Formule :C25H33F3N6O2Couleur et forme :SolidMasse moléculaire :506.56BAY-3153
CAS :BAY-3153 is a selective CCR1 ( C-C motif chemokine receptor 1 ) antagonist (human IC 50 =3 nM ; rat IC 50 =11 nM ; mice IC 50 =81 nM) .Formule :C25H29Cl2N3O4Couleur et forme :SolidMasse moléculaire :506.42INCB-9471 dihydrochloride
CAS :INCB-9471 HCl: a potent CCR5 antagonist, blocks monocyte migration & HIV-1.Formule :C30H42Cl2F3N5O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :632.59CCR7 Ligand 1
CAS :CCR7-Cmp2105 is a thiadiazole-dioxide allosteric antagonist for CCR7 with a Kd of 3 nM and IC50 of 7.3 μM against arrestin binding.Formule :C22H29N5O5SCouleur et forme :SolidMasse moléculaire :475.56MK-0812
CAS :MK-0812 is a dual antagonist of the CCR2 and CCR5 receptors that can alleviate adipose inflammation in ob/ob mice.Formule :C24H34F3N3O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :469.54CP-865569
CAS :CP-865569 is a CCR1 antagonist useful in the research of inflammatory and autoimmune diseases, including conditions such as rheumatoid arthritis and multiple sclerosis.Formule :C22H26ClFN2O5SCouleur et forme :SolidMasse moléculaire :484.969CXCR2/CCR7 antagonist-1
CAS :CXCR2/CCR7 antagonist-1 (compound 6) is a potent dual antagonist of CXCR2 and CCR7, with IC50 values of 0.0046 μM and 0.0014 μM, respectively. It is valuable for research in tumor metastasis and autoimmune diseases.Formule :C23H27N3O5Couleur et forme :SolidMasse moléculaire :425.48CCR3 antagonist 2
CAS :CCR3 antagonist2 (example 66) is a CCR3 antagonist useful for researching inflammatory or allergic diseases, particularly those affecting the respiratory tract, such as inflammatory or obstructive airway conditions.Formule :C21H28ClN5O3Couleur et forme :SolidMasse moléculaire :433.93BI 639667
CAS :BI 639667, an azaindazole-class compound, potently inhibits CCR1 (IC50=1.8 nM in calcium flux assays).Formule :C22H18FN5O3SDegré de pureté :99.86%Couleur et forme :SolidMasse moléculaire :451.47CP-481715
CAS :CP 481715 is an effective selective CCR1 antagonist with potential therapeutic significance for inflammatory diseases.Formule :C26H31FN4O4Couleur et forme :SolidMasse moléculaire :482.55Nifeviroc
CAS :Nifeviroc (TD-0232) is an orally active CCR5 antagonist, useful in HIV-1 infection research.Formule :C33H42N4O6Degré de pureté :98.14%Couleur et forme :SolidMasse moléculaire :590.71TAK-661
CAS :TAK-661 is an inhibitor of eosinophil chemotaxis (eosinophil chemotaxis) that significantly alleviates late-phase bronchoconstriction while inhibiting the proliferation of eosinophils in bronchoalveolar lavage (BAL) and their infiltration into the airway walls.Formule :C13H21N5O3SCouleur et forme :SolidMasse moléculaire :327.40Ophiobolin C
CAS :inhibitor of human CCR5 binding to HIV-1 gp120Formule :C25H38O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :386.57AZD-5672
CAS :AZD-5672 is an antagonist of CCR5 with an IC50 of 0.32 nM.Formule :C32H38F2N2O5S2Degré de pureté :98.1%Couleur et forme :SolidMasse moléculaire :632.78Ref: TM-T30260
1mg192,00€5mg434,00€10mg610,00€25mg888,00€50mg1.243,00€100mg1.693,00€1mL*10mM (DMSO)530,00€GSK-3050002
GSK-3050002 (HGS-1035) is a humanized IgG1 antibody that targets and binds to CCL20. It holds potential for inflammation research. For isotype control, refer to Human IgG1 kappa, Isotype Control.
Couleur et forme :Odour LiquidBX471 hydrochloride
CAS :BX471 hydrochloride (ZK-811752 hydrochloride) is a potent, selective non-peptide CCR1 antagonist with a Ki of 1 nM for human CCR1, exhibiting 250-fold selectivity over CCR2, CCR5, and CXCR4.Formule :C21H25Cl2FN4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :471.35
